Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

GYREGYRE
Showing 8 of 11 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in GYRE THERAPEUTICS INC

Yes. Geode Capital Management holds 532,950 shares of GYRE (Gyre Therapeutics), worth $3.5M, as of its Q2 2026 13F filing. It increased the position by 101,536 shares (+23.5%) from Q1 2026. Geode Capital Management has held GYRE since Q4 2023, across 11 quarterly 13F filings.

Current Value

$3.5M

Current Shares

532,950

Total Value Change

-$295,272

Total Shares Change

+229,303

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
532,950
+23.5%
$3.5M0.0%$6.59
32
2026-Q1
Increased
431,414
+1.9%
$3M0.0%$6.97
27
2025-Q4
Increased
423,222
+13.0%
$3M0.0%$7.06
30
2025-Q3
Decreased
374,620
-6.7%
$2.8M0.0%$7.46
0
2025-Q2
Increased
401,709
+28.6%
$3M0.0%$7.35
33
2025-Q1
Increased
312,319
+2.7%
$2.4M0.0%$7.72
27
2024-Q4
Increased
304,098
+0.1%
$3.7M0.0%$12.10
27
2024-Q3
Increased
303,647
+16.9%
$3.8M0.0%$12.54
31

Other major holders of GYRE: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used